Country Industry Forecast - Economic Analysis for the United Kingdom Healthcare Industry

 

Regular Price: USD 450

Special Price USD 315

30% OFF

* Required Fields

Regular Price: USD 450

Special Price USD 315

PAY BY INVOICE

Be the first to review this product

The U.K. healthcare industry is growing at an annual rate of 10.0 percent. The pharmaceuticals segment is the third most profitable economic activity in the country, after tourism and finance. The exports of pharmaceutical products have been increasing continuously since last ten years. In 2004, 18.0 percent of the world’s top 100 prescription drugs and around one in five world’s best selling drugs were developed in the United Kingdom. The Country Industry Forecast gives an indepth analysis of how United Kingdom's recent changes in the economic policies that have affected the Healthcare Industry and created opportunities for it.

Table of Contents

Country Industry Forecast - Economic Analysis for the United Kingdom Healthcare Industry, Healthcare IndustryHealthcare IndustryHealthcare Industry OverviewHealthcare Expenditure in the U.K.Healthcare Expenditure to Increase in the United KingdomThe United Kingdom Government’s Initiatives to Improve Healthcare Services in the CountryInitiatives to Improve Healthcare ServicesCountry Industry Forecast - Economic Analysis for the United Kingdom Healthcare Industry, Economic EnvironmentEconomic OverviewThe U.K. Economy Shows Signs of RecoveryU.K. Government and Healthcare IndustryU.K. Government to Cash on the Savings Arising out of Increasing Substitution of Generic Drugs Country Industry Forecast - Economic Analysis for the United Kingdom Healthcare Industry, Business PoliciesFiscal PolicyFiscal Policy in U.K.Tax Burden in U.K.U.K. and the European Monetary UnionU.K. and the EMUCountry Industry Forecast - Economic Analysis for the United Kingdom Healthcare Industry, Economic Policies and Healthcare IndustryPharmaceuticals and Biotechnology SegmentOverview of the U.K. Pharmaceutical SegmentOverview of the U.K. Biotechnology SegmentMedical Devices and Equipment SegmentOverview of Medical Devices and Equipment SegmentMedical Imaging Segment Overview of Medical Imaging MarketHealthcare and LifeScience ITModernization of Healthcare Delivery System with the Introduction of IT Drug Discovery & Clinical Diagnostics Segment Drug Discovery and Clinical Trials in the U.K.Growth Prospects in the U.K. Healthcare IndustryOpportunities and Challenges in the U.K. Healthcare Industry




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.